Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan N Chi

Showing results (21-30 of 83) with videos related to

Pageof 9
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2019
Revisiting the Role of Radiation Therapy for Pediatric Low-Grade GliomaDanielle S Bitterman, Shannon M MacDonald, Torunn I Yock, et al.
Pediatric Blood & Cancer|September 22, 2012
Absence of oncogenic canonical pathway mutations in aggressive pediatric rhabdoid tumorsMark W Kieran, Charles W M Roberts, Susan N Chi, et al.
Journal of Neuro-Oncology|August 2, 2022
An international study evaluating the epidemiology of intracranial germ cell tumors in the native versus immigrant Japanese populations: the need for an international registryAshley S Plant-Fox, Tomonari Suzuki, Rosdali Y Diaz Coronado, et al.
Journal of Neuro-Oncology|August 12, 2020
Trametinib for the treatment of recurrent/progressive pediatric low-grade gliomaNeevika Manoharan, Jungwhan Choi, Christine Chordas, et al.
Journal of Neuro-Oncology|April 2, 2005
Continuous remission of newly diagnosed and relapsed central nervous system atypical teratoid/rhabdoid tumorMary Ann Zimmerman, Liliana C Goumnerova, Mark Proctor, et al.
Molecular Cancer Therapeutics|September 13, 2022
p53 Pathway Inactivation Drives SMARCB1-deficient p53-wildtype Epithelioid Sarcoma Onset Indicating Therapeutic Vulnerability Through MDM2 InhibitionFelix Oppel, Senyao Shao, Sarah Gendreizig, et al.
Journal of Neurosurgery. Pediatrics|July 26, 2014
Recurrence after gross-total resection of low-grade pediatric brain tumors: the frequency and timing of postoperative imagingAlbert H Kim, Elizabeth A Thompson, Lance S Governale, et al.
Pediatric Neurology|August 1, 2006
Transverse myelitis after therapy for primitive neuroectodermal tumorsNicole J Ullrich, Karen Marcus, Scott L Pomeroy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2010
Lack of efficacy of bevacizumab plus irinotecan in children with recurrent malignant glioma and diffuse brainstem glioma: a Pediatric Brain Tumor Consortium studySridharan Gururangan, Susan N Chi, Tina Young Poussaint, et al.
Journal of Pediatric Hematology/Oncology|November 12, 2005
A feasibility trial of antiangiogenic (metronomic) chemotherapy in pediatric patients with recurrent or progressive cancerMark W Kieran, Christopher D Turner, Joshua B Rubin, et al.
Pageof 9

Showing results (21-30 of 83) with videos related to

Sort By:
Pageof 9
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2019
Revisiting the Role of Radiation Therapy for Pediatric Low-Grade GliomaDanielle S Bitterman, Shannon M MacDonald, Torunn I Yock, et al.
Pediatric Blood & Cancer|September 22, 2012
Absence of oncogenic canonical pathway mutations in aggressive pediatric rhabdoid tumorsMark W Kieran, Charles W M Roberts, Susan N Chi, et al.
Journal of Neuro-Oncology|August 2, 2022
An international study evaluating the epidemiology of intracranial germ cell tumors in the native versus immigrant Japanese populations: the need for an international registryAshley S Plant-Fox, Tomonari Suzuki, Rosdali Y Diaz Coronado, et al.
Journal of Neuro-Oncology|August 12, 2020
Trametinib for the treatment of recurrent/progressive pediatric low-grade gliomaNeevika Manoharan, Jungwhan Choi, Christine Chordas, et al.
Journal of Neuro-Oncology|April 2, 2005
Continuous remission of newly diagnosed and relapsed central nervous system atypical teratoid/rhabdoid tumorMary Ann Zimmerman, Liliana C Goumnerova, Mark Proctor, et al.
Molecular Cancer Therapeutics|September 13, 2022
p53 Pathway Inactivation Drives SMARCB1-deficient p53-wildtype Epithelioid Sarcoma Onset Indicating Therapeutic Vulnerability Through MDM2 InhibitionFelix Oppel, Senyao Shao, Sarah Gendreizig, et al.
Journal of Neurosurgery. Pediatrics|July 26, 2014
Recurrence after gross-total resection of low-grade pediatric brain tumors: the frequency and timing of postoperative imagingAlbert H Kim, Elizabeth A Thompson, Lance S Governale, et al.
Pediatric Neurology|August 1, 2006
Transverse myelitis after therapy for primitive neuroectodermal tumorsNicole J Ullrich, Karen Marcus, Scott L Pomeroy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2010
Lack of efficacy of bevacizumab plus irinotecan in children with recurrent malignant glioma and diffuse brainstem glioma: a Pediatric Brain Tumor Consortium studySridharan Gururangan, Susan N Chi, Tina Young Poussaint, et al.
Journal of Pediatric Hematology/Oncology|November 12, 2005
A feasibility trial of antiangiogenic (metronomic) chemotherapy in pediatric patients with recurrent or progressive cancerMark W Kieran, Christopher D Turner, Joshua B Rubin, et al.
Pageof 9